Business Context and Reporting Period
This Form 8-K reports on the results of uniQure N.V.'s 2020 Annual General Meeting of Shareholders (AGM) held on June 17, 2020. The company, incorporated in The Netherlands and listed on the Nasdaq Global Select Market under the symbol QURE, is classified as an emerging growth company. The filing details shareholder votes on governance matters, including the adoption of 2019 statutory accounts, director appointments, and authorizations for share issuance and repurchase.
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial performance data. Consequently, there are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document. The filing references the adoption of the 2019 Dutch statutory annual accounts but does not disclose the specific financial figures contained therein.
Material Changes and Shareholder Votes
The AGM resulted in the following key outcomes based on 44,325,874 eligible ordinary shares:
- Adoption of 2019 Accounts: Approved with 35,218,156 votes in favor versus 92,057 against.
- Board Discharge: The Board of Directors was granted discharge for the 2019 financial year with 35,271,316 votes in favor versus 21,275 against.
- Director Appointments:
- Reappointment of Madhavan Balachandran, Jack Kaye, and Jeremy Springhorn as non-executive directors was approved.
- Appointment of Leonard Post as a non-executive director was approved with 35,334,726 votes in favor.
- Share Issuance Authority: The Board was designated as the competent body to issue shares and grant subscription rights (27,366,516 for; 7,975,842 against).
- Preemptive Rights: The Board was reauthorized to exclude or limit preemptive rights (23,000,610 for; 8,010,390 against).
- Share Repurchase Program: The Board was authorized to repurchase up to 10% of issued share capital for 18 months (35,311,599 for; 22,168 against).
- Auditor Appointment: KPMG Accounts N.V. was appointed as the external auditor for 2020 (35,347,699 for; 2,387 against).
- Executive Compensation: Advisory approval of named executive officer compensation was granted (34,901,273 for; 445,724 against).
Guidance, Outlook, and Risks
The filing does not provide management commentary, financial guidance, or an outlook for future periods. It also does not disclose specific risks or contingencies beyond the standard governance procedures outlined in the proxy statement referenced in the text.
Investor Verification Checklist
- Verify the specific financial figures in the 2019 Dutch statutory annual accounts, as they were adopted but not detailed in this 8-K.
- Review the full proxy statement for details on the compensation of named executive officers approved in Agenda Item XI.
- Monitor the execution of the newly authorized share repurchase program (up to 10% of capital) over the next 18 months.
- Confirm the terms of the new auditor engagement with KPMG for the 2020 financial year.